Selecting Temperature for Protein Crystallization Screens Using the Temperature Dependence of the Second Virial Coefficient by Liu, Jun et al.
Selecting Temperature for Protein Crystallization Screens
Using the Temperature Dependence of the Second Virial
Coefficient
Jun Liu, Da-Chuan Yin*, Yun-Zhu Guo, Xi-Kai Wang, Si-Xiao Xie, Qin-Qin Lu, Yong-Ming Liu
Key Laboratory for Space Bioscience and Biotechnology, School of Life Sciences, Northwestern Polytechnical University, Xi’an, Shaanxi, People’s Republic of China
Abstract
Protein crystals usually grow at a preferable temperature which is however not known for a new protein. This paper reports
a new approach for determination of favorable crystallization temperature, which can be adopted to facilitate the
crystallization screening process. By taking advantage of the correlation between the temperature dependence of the
second virial coefficient (B22) and the solubility of protein, we measured the temperature dependence of B22 to predict the
temperature dependence of the solubility. Using information about solubility versus temperature, a preferred crystallization
temperature can be proposed. If B22 is a positive function of the temperature, a lower crystallization temperature is
recommended; if B22 shows opposite behavior with respect to the temperature, a higher crystallization temperature is
preferred. Otherwise, any temperature in the tested range can be used.
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Introduction
After the successful accomplishments of the Human Genome
Project (HGP), more and more scientists have concentrated
considerable interest on solving molecular-based diseases, which
can be treated by structure-based rational drug design. Obtaining
the 3-dimensional structure of the target biomacromolecules,
which are often proteins, is the key to success in achieving this
goal. Due to the potentially important applications of the
structural information in human health, researchers have been
making broad efforts to investigate the structures and functions of
many proteins. It is well known that X-ray crystallography is the
most widely used method to determine the 3-dimensional structure
of proteins. More than 85% of the structures in the PDB (www.
pdb.org) were determined by this method, which requires high
quality protein crystals as diffraction targets. However, due to the
complexity in crystal nucleation and growth, obtaining satisfactory
protein crystals is often the rate-limiting step for structure
determination. For example, over 60% of the targets for most
commercial therapeutic drugs are membrane proteins [1,2], which
are usually hard to crystallize. Therefore, growing high quality
protein crystals is an important task for structural biologists [3,4].
Generally, it is accepted that if we could understand more
clearly the behaviors of crystal nucleation and growth under
various conditions, we would better know how to proceed with
crystallization. To determine the structure of a protein using X-ray
crystallography, the first step (after purification of the protein) is to
find suitable conditions for crystallization (crystallization screen-
ing). Then, based on the screening results, the goal is to optimize
the crystal quality for the purposes of high resolution diffraction.
Since there are still no general guidelines for growing high quality
protein crystals, these steps are often based on trial and error,
which consumes time, money and manpower. To expedite the
process and reduce the cost, rational protein crystallization has
been proposed, and many efforts have been made [5–13]. Among
these efforts, DLS (Dynamic Light Scattering) and SLS (Static
Light Scattering) are often used. A famous coefficient of a protein
solution, the second viral coefficient (B22), is familiar to protein
crystal growers [14–16] and is derived from the SLS method. B22
is a static parameter that is related to the molecular weight of the
protein [17]. For protein crystal growers, the B22 value is a useful
parameter because it can indicate which solutions are not
favorable for crystallization. A ‘‘crystallization slot’’ of B22, which
is in the range of about 21610
24 to 28610
24 mol?mL?g
22 [18],
has been reported to be helpful. A B22 value in this range does not
guarantee successful crystallization, but a value outside of the slot
will probably result in crystallization failure. By varying protein
solution conditions (such as adding crystallization agents and
additives or adjusting pH), B22 values may be adjusted to fall well
within the slot, which may favor crystallization [19,20].
It isnowclearthat theabsolutevaluesofB22areaffected bymany
factors, such as the characteristics of the particles in the protein
solution, pH, intermolecular surface potential and temperature
[21]. Probing the relationship between B22 and these factors may
help to develop a rational strategy to determine the best
crystallization parameters. For example, it has been reported that
the temperature dependence of B22 shows the same tendencies as
the temperature dependence of the solubility [22,23]. This result
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select a suitable crystallization temperature because the driving
force of crystallization is strongly related to the solubility.
The driving force of protein crystallization is the difference in
chemical potential between the supersaturated and equilibrium
solutions, which is mainly determined by the supersaturation (s),
i.e., the ratio of the solution concentration to the solubility (s).
Therefore, the solubility is a crucial parameter for protein
crystallization. Because the solubility usually depends on the
temperature, it can be adjusted by changing the temperature. The
driving force of the crystallization can thus be adjusted by selecting
a suitable temperature. In routine protein crystallization screens,
researchers usually choose the crystallization temperature arbi-
trarily because they don’t have a better method. For example, a
typical temperature, like 277K, is often used. If we have
information about how the solubility changes in relation to
temperature, which can be inferred from the results of a B22
temperature dependence measurement, we may rationally propose
a suitable temperature for crystallization screens.
To demonstrate this idea, we measured the temperature
dependence of B22 for lysozyme, proteinase K, concanavalin A
and a-chymotrypsinogen A(II) in different solution conditions
respectively (detailed solution conditions are listed in Table 1), and
verified with reproducibility and crystallization screening studies
that optimal temperatures can be selected according to the
temperature dependence behavior of B22.
Materials and Methods
Materials and experimental instruments
Four proteins were used in this study. Hen egg white lysozyme
(HEWL, Lot No. 100940, recrystallized six times) was purchased
from Seikagaku Kogyo Co. (Japan), and proteinase K (Lot No.
P6556), a-chymotrypsinogen A(II) (Lot No. C4879) and conca-
navalin A (Lot No. L7647) were purchased from Sigma-Aldrich
Co. (USA).
Sodium chloride (NaCl) was obtained from Tianjin Kermel
Chemical Reagents Development Center (China). Sodium acetate
and HEPES-Na [C8H17N2O4SNa] were obtained from Beijing
Chemical Factory (China). Both acetone and toluene were
analytical reagents from Henan Mol Chemical Co., Ltd. (China).
Acetic acid (HPLC grade) was obtained from TEDIA Co. (USA).
The crystallization screening kit was Index
TM from Hampton
Research Co. (USA). Sodium cacodylate trihydrate, Polyethylene
glycol (PEG) 8000 and PEG 3350 were purchased from Sigma-
Aldrich Co.(USA). Magnesium acetate was taken from Tianjin
Chemical Reagent Co., Ltd. (China). Citric acid was obtained
from Tianjin Dongli Chemical Reagent Factory (China). Tris
hydrochloride (Tris-HCl) was purchased from Shanghai Fanke
Biotechnology Co., Ltd (China).
Measurement of pH was carried out using a digital pH meter
(Sartorius PB-10, Sartorius Scientific Instruments Co., Ltd.,
Beijing, China.). Water was prepared using a Nanopure Diamond
Ultrapure Water System D11931 from Barnstead Co. (USA).
All prepared solutions were filtered through 0.1 mm low protein
binding non-pyrogenic syringe filters (PN: 4611) from Pall China
(Beijing, China).
The PCS8501-glass cuvette with round aperture, the container
for B22 measurement, was obtained from Malvern Company
(Beijing, China).
In the reproducibility study, 40-well plates (Keyu Co., Jiangsu,
China) were used as crystallization plates, and 96-well crystalliza-
tion plates (HR3-143, Hampton Research Co., USA) were used in
crystallization screens.
The refractive index of protein solutions was measured by an
Abbe Refractometer (Shanghai Changfang Optical Instruments
Co., LTD, China). Weight measurements were carried out using a
microbalance BS 224S (Sartorius AG Beijing, China). The sample
concentration after light scattering measurement was detected by a
UV Spectrophotometer U-3310 (Hitachi Technologies Co.,
Japan). B22 was measured by a Nano Zetasizer (Nano-ZS,
Malvern Instruments Ltd., UK).
The crystallization trials were set up using an automated protein
crystallization robot (Screenmaker 96+8, Innovadyne Technolo-
gies Inc. USA).
The resulting samples were examined by an automated crystal
image reader (XtalFinder, XtalQuest Inc., China).
Measurement of B22
Principle. The molecular weight and the second virial
coefficient of a protein sample in a solution can be measured
Table 1. Solution conditions for measuring B22.
A)
Proteins Buffer
Lys. 25 mM HEPES-Na, pH 7.0
Pro. K 25 mM HEPES-Na, pH 7.0
Chy. A 25 mM HEPES-Na, pH 7.0
Con. A 25 mM HEPES-Na, pH 7.0
B)
Proteins Buffer Crystallization agents
Lys. 20 mM NaAc, pH 4.6 12 mg/mL NaCl
Pro. K 5 mM HEPES-Na, pH 7.0 10 mM sodium cacodylate trihydrate; 16 mM MgAc2 and 5%w/v PEG8000,
pH 6.5
Chy. A 20 mM citric acid, pH 3.5 and 2.5%w/v PEG3350 5%w/v PEG3350
Con. A 5 mM HEPES-Na, pH 7.0 20 mM Tris-HCl and 1.6%w/v PEG8000, pH 8.5
A): in the absence of crystallization agents; B): in the presence of crystallization agents. Lys.: lysozyme; Pro. K: proteinase K; Chy. A: a-chymotrypsinogen A (II); Con. A:
concanavalin A.
doi:10.1371/journal.pone.0017950.t001
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analyzed using the classical Zimm equation [24,25]:
KC
R173
~
1
MW
z2B22Cz   , ð1Þ
where C is the concentration, R173 is the excess Rayleigh factor at
a scattering angle of 173u, Mw is the molecular weight, and K is an
optical constant given by
K~
4p2n2(dn=dC)
2
NAl
4 ð2Þ
where n is the refractive index, NA is Avogadro’s number and l is
the wavelength of the detecting light.
Using the above equations, the Debye plot, which is the
dependence of the solution’s scattering intensity on the concen-
tration, can be plotted. Both B22 and Mw can then be derived
simultaneously from the Debye plot. A detailed method can be
found in the literature [26].
Measurements. Determination of protein concentration: an
accurate protein concentration is important to calculate B22. The
concentration levels of the proteins are preset to 0.5 mg/mL,
1.0 mg/mL, 3.0 mg/mL, 5.0 mg/mL, 7.0 mg/mL and 9.0 mg/
mL. However, the exact concentration will normally deviate from
the preset point. Therefore, to obtain reliable concentration data,
we used the calculated concentration based on the actual values of
solution volume and protein weight during the experiment.
Determination of dn/dC: from Eq. (2), the dn/dC value should be
determined prior to the SLS measurement. We used an Abbe
Refractometer to measure the refractive index at different
concentration levels. Then, the dn/dC value was derived from
the data using a linear regression treatment [27].
Cleaning of quartz sample cells: to obtain highly precise results
in DLS and SLS measurements, the sample solution should be free
of dust. If there is dust in the quartz sample cells or dirt on the cell
wall, the measurement results will be scattered. Therefore,
cleaning the quartz sample cells is very important.
We used the following cleaning procedure, which proved to be
useful to enhance measurement reproducibility. First, wash the
sample cell twice using distilled water and wipe with cotton swabs;
then, rinse and dry the cells in a vacuum oven at 308K. Next,
spray the sample cell with acetone or ethanol by using a syringe.
Finally, wrap the sample cell with aluminum foil, which has itself
been dunked in acetone to remove dust, to keep dust from entering
the cell. Dry the cells in the ambient environment.
SLS & DLS measurements: we used SLS measurements to
obtain B22 from the Debye Plot at different temperatures.
Simultaneously, we performed DLS measurements using the same
system. The DLS measurements were used to characterize the
particle size distribution in the tested solution so as to get
information on solution dispersity. To get a reliable Debye Plot,
the solution should be monodisperse. If the DLS measurements
show that the solution is not monodisperse, the SLS data must be
discarded, and the experiments performed again.
Crystallization screening and crystallization
reproducibility tests
According to the results of the temperature dependence of B22,
we may postulate about the temperature dependence trends of the
solubility. In low solubility conditions, a high probability of
crystallization or precipitation might be achieved. To verify this
postulate, we carried out both crystallization screening and
crystallization reproducibility tests. In the crystallization screening
tests, four proteins were tested at the following temperatures:
277K, 289K and 301K. All proteins are dissolved in 25 mM
pH 7.0 HEPES-Na. Initial protein concentrations (before mixing)
were 20 mg/mL for lysozyme, 20 mg/mL for a-chymotrypsino-
gen A(II), 10 mg/mL for concanavalin A and 30 mg/mL for
proteinase K [17,28]. In the crystallization reproducibility tests,
one protein (a-chymotrypsinogen A(II)) was tested at 277K and
293K. For comparison, crystallization reproducibility data for the
other three proteins were extracted from previously published
results.
Results and Discussion
Measurement results of B22
Concentration dependence of refractive index (dn/
dC). The refractive indices of the four proteins were measured
at different concentration levels. Nearly the same measurement
results were obtained for all tested proteins. Fig. 1 gives the
measurement results for lysozyme. From the figure, it can be
derived that the value of dn/dC was about 0.15 mL/g for proteins
dissolved in a buffer of 25 mM pH 7.0 HEPES-Na. This value has
been proven to be stable in the buffer and insensitive to the
temperature change in the range between 277K and 303K.
Therefore we used 0.15 mL/g as the value of dn/dC in the SLS
measurement.
Concentration after SLS measurement. To make sure
that the concentration data used in the SLS measurements are
correct, we measured the concentration of the proteins using a UV
Spectrophotometer after the SLS measurement. The results
showed that there are only subtle differences between the
measured results and the calculated results using the actual
solution volume and weight of the proteins.
Obtaining a reliable Debye plot. A Debye plot is
constructed by passing incident light through the protein
solution and measuring scattered light intensity to see how the
light interacts with the particles in the solution. Dust with
diameters between 1 mm and 10 mm, which is about 100 times
the size of the protein molecules, can ruin the experiment. By
using a 0.1 mm filter, we successfully avoided introducing dust into
the solution during solution preparation.
However, it is still very hard to completely prevent dust particles
in the air from entering the solution when transferring the protein
solution into the sample cell. Therefore, to make sure that the
Figure 1. Linear regression of refractive index versus concen-
tration of lysozyme (dn/dC). It can be derived that the dn/dC value is
equal to 0.15 mL/g for all tested proteins in a buffer of 25 mM pH 7.0
HEPES-Na.
doi:10.1371/journal.pone.0017950.g001
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solution, we performed a DLS measurement at the same time to
check the monodispersity of the solution. Figs. 2(a) and (b) show
examples of a DLS measurement of particle size distribution in the
tested solution. From the figure, we can see that the solution
presented in Fig. 2A was not monodisperse; therefore, we
discarded the SLS measurement data for the corresponding
solution. In Fig. 2B, the solution is monodisperse and thus the
results of the SLS measurement were considered reliable and safe
to use.
The temperature dependence of B22. The temperature
dependence of B22 in several proteins was obtained by measuring
B22 at different temperatures for each protein. Fig. 3A shows the
measurement results when the proteins were dissolved in the buffer
only (i.e., without crystallization agents). It can be seen that
lysozyme showed a ‘‘normal’’ temperature dependence of B22, i.e.,
B22 increases with increasing temperature in the tested
temperature range. Proteinase K, however, showed an opposite
temperature dependence of B22. The value of B22 for the other two
proteins, concanavalin A and a-chymotrypsinogen A(II), seemed
not to be very sensitive to the temperature, though B22 of the
former decreased slightly with increasing temperature while that of
the latter increased slightly with the temperature. Fig. 3B shows
the measurement results when crystallization agents were used in
the solutions. Although the absolute values of B22 presented in
Fig. 3B appears smaller than their counterparts in Fig. 3A, the
temperature dependence of B22 showed the same tendency against
the temperature. Obviously, this result indicated that testing the
temperature dependence of B22 can be carried out without using
crystallization agents.
Crystallization studies
As reported in the literature [15,21,23,29–31], the temperature
dependence of B22 can be an indication of the temperature
dependence of the solubility. This rule may be used to guide the
crystallization screens of proteins because the solubility is closely
related to the supersaturation, which is the driving force of
crystallization. A ‘‘normal’’ behavior of B22 against temperature
indicates a ‘‘normal’’ behavior of solubility versus temperature,
i.e., the solubility increases with the temperature. In such cases, a
solution at a certain concentration will exhibit a higher
supersaturation level at lower temperature. The solution will thus
exhibit a high driving force for the crystallization, which is
beneficial for enhancing the success rate of crystallization. To
examine this speculation, we carried out crystallization studies
using the four proteins whose B22 values had been measured. Both
crystallization screening and crystallization reproducibility tests
were used in this study.
Crystallization screening tests. For the screening tests, we
used the two temperatures of 289K and 301K, which marked the
ends of the tested temperature range in our B22 measurement. To
further check the crystallization outside the above temperature
range, we also tested the crystallization screens at a lower but
frequently used temperature of 277 K.
Fig. 4 shows the results of the crystallization screening tests. It
can be seen that, in the case of crystallization of lysozyme, the
Figure 2. DLS measurement results for the particle size distribution of the tested solutions of a-chymotrypsinogen A(II). All proteins
are dissolved in 25 mM pH 7.0 HEPES-Na at 295K. A): Two peaks appeared, showing that the solution was not monodisperse; B): Only one peak
appeared, showing that the solution was monodisperse, and its corresponding SLS measurement result was considered reliable and the data could
be included for subsequent analysis.
doi:10.1371/journal.pone.0017950.g002
Figure 3. Temperature dependence of B22 for the tested
proteins. A): without crystallization agents; B): with crystallization
agents. Refer to Table 1 for detailed solution conditions. Lys.: lysozyme;
Pro.K: proteinase K; Con.A: concanavalin A; Chy.A: a-chymotrypsinogen
A(II).
doi:10.1371/journal.pone.0017950.g003
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the 96 crystallization conditions that yielded detectable crystals
under a stereomicroscope at 806magnification) was higher at
lower temperature. The difference in screening hits at different
temperatures was clear: the screening hits were 24.8% greater at
277K than at 301K. In the case of crystallization of a-
chymotrypsinogen A(II), we also observed similar trends in
screening hits as seen in lysozyme crystallization, but the difference
in screening hits for this protein was not very obvious: the
screening hits were only 4.7% greater at 277K than at 301K.
Thus, the change was relatively insensitive to the temperature just
as the temperature variation of B22 for a-chymotrypsinogen A(II)
was small compared with that for lysozyme.
As expected, in the case of crystallization of proteinase K, which
exhibits opposite behavior of B22 versus temperature, the screening
hits were greater at higher temperature. In the case of
crystallization of concanavalin A, we observed a similar trend to
proteinase K (screening hits were 15.5% greater at 301K than at
277K for proteinase K and 14.1% greater for concanavalin A),
though the B22 value of the latter only slightly decreased with
increasing temperature.
Fig. 5 shows a comparison of typical crystal images for each of
the tested proteins at the three screening temperatures. From the
figure it can be seen that the crystal number showed the tendency
against the crystallization temperature as predicted by B22
measurement.
Crystallization reproducibility tests. It is well known that
protein crystallization often suffers from the problem of bad
reproducibility [32,33], i.e., identical crystallization conditions
may not yield identical crystallization results. By setting up a
number of crystallization drops at identical crystallization
conditions, we can easily check the reproducibility of the
crystallization of a protein. The major application of a
reproducibility test in this study is to statistically clarify the trend
of the crystallization success rate versus the temperature.
In our recent publications, we have already presented some
reproducibility studies at two temperatures (277K and 293K) [34],
which can be used in the current study to show the trend of
crystallization success rate versus the temperature. We extracted
the data for reproducibility tests of three proteins (lysozyme,
Figure 4. Crystallization screening hits for the tested proteins at different temperatures. The proteins used were as follows: A): lysozyme;
B): proteinase K; C): a-chymotrypsinogen A(II); D): concanavalin A. The screening kit was Index
TM from Hampton Research. The results showed that a
protein yielded higher crystallization success rate at the temperature where the B22 value of the solution was relatively lower. Error bar: standard error
mean; n=6.
doi:10.1371/journal.pone.0017950.g004
Figure 5. Comparison of typical crystal images of the tested
proteins at screening temperatures of 277K, 289K and 301K.
The screening kit was Index
TM from Hampton Research. A1,A 2,A 3:
lysozyme crystals obtained at C7; B1,B 2,B 3: proteinase K crystals
obtained at B10; C1,C 2,C 3: concanavalin A crystals obtained at H8; D1,
D2,D 3: a-chymotrypsinogen A(II) crystals obtained at G6. Initial
concentration of all proteins was 20 mg/mL. A1,B 1,C 1,D 1: 277K; A2,
B2,C 2,D 2: 289K; A3,B 3,C 3,D 3: 301K. This figure shows that the crystal
number varied with crystallization temperature as predicted by the
measurement of B22.
doi:10.1371/journal.pone.0017950.g005
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[34] and carried out a new crystallization reproducibility test of a-
chymotrypsinogen A(II). Fig. 6 shows the results. From the figure,
we can see that the crystallization success rate of these four
proteins follows the same trends versus temperature as seen in the
above crystallization screens section. The trend was especially
clear in the cases of crystallization of lysozyme (Fig. 6A) and
concanavalin A (Fig. 6D). In the case of a-chymotrypsinogen A(II)
(Fig. 6C), the trend was not so clear; this result was similar to the
results obtained in the screening tests (Fig. 4C). In conclusion, the
crystallization reproducibility studies shown here confirm the
results obtained in the screening tests.
From different sources in the literature, we also found an
example which supports our hypothesis. Wilson et al. [18]
reported that B22 of thaumatin I exhibits no temperature
dependence, which implies an insensitive temperature dependence
of its solubility. In our previous publication [33], we presented a
variable temperature strategy to screen the crystallization
conditions, which showed that the crystallization success rate of
thaumatin is not sensitive to the temperature. This result implied
that the solubility of thaumatin is insensitive to the temperature
too. Apparently, the above two experimental results are in good
agreement with each other and can be used as a good example to
confirm our current research results.
Potential application in protein crystallization screens
As demonstrated above, the results of the crystallization studies
were clearly in agreement with the theoretical speculation. In
other words, knowing the temperature dependence of B22 may be
a good tool to select a suitable temperature for protein
crystallization screens. The guideline could be as follows: when
B22 is lower at a lower temperature (indicating a lower solubility at
lower temperature), a lower screening temperature, e.g., 277K, is
preferred; when B22 is higher at a lower temperature (indicating a
lower solubility at higher temperature), a higher screening
temperature is preferred, depending on the crystallization method
and the protein. For example, only at 318K can crystal growers
obtain the diffraction-quality crystals of an antifreeze protein [35].
In the rare case where B22 is insensitive to temperature, any
temperature in the range where the protein is stable can be used.
There is a practical consideration about the consumption of the
protein to address before this method can be applied in protein
crystallization screens. In our current research, we used a normal
cuvette to measure B22, which requires 1.2 mL of protein solution
for each single measurement. Therefore, to obtain a complete
temperature dependence of B22 with this method, approximately
26 mg of protein is necessary. This amount is too large to use in
actual crystallization because proteins are usually very precious
and difficult to obtain in large amounts (to ensure the homogeneity
of the sample). Fortunately, if we use the Low-volume quartz batch
cuvette ZEN2112 (Malvern Instruments Ltd., UK), the total
amount of protein consumed can be reduced to less than 2 mg.
The amount of consumed protein can be further reduced to 30-
300 mg by using a light scattering technique developed to analyze
droplets because droplet volume can be reduced to less than 1 mL
[10]. In such cases, it would be easy to apply the method without
any large sample consumption.
Conclusions
In this paper, we presented an alternative method to help crystal
growers determine a favorable temperature for protein crystalli-
zation screens by using knowledge of the temperature dependence
of the second virial coefficient B22. This information is a good
indicator of the temperature dependence of the solubility of the
protein. By using this method, we examined the crystallization
success rate of four proteins in both crystallization screening and
crystallization reproducibility studies. We verified that the
temperature dependence of B22 may be used as an indicator to
choose a favorable crystallization temperature, which can help to
increase the crystallization success rate.
Figure 6. Crystallization reproducibility tests of the four proteins at temperatures of 277K and 293K. Part of the data (Fig. 6A, B and D)
in this figure were extracted from published results [34] (n=7). Crystallization methods: hanging drop. Initial crystallization conditions: A): lysozyme
(Lys.) solution: 20 mg/mL in 0.1 M sodium acetate (pH=4.6), reservoir solution: 60 mg/mL NaCl; B): proteinase K (Pro.K) solution: 20 mg/mL in 25 mM
HEPES-Na (pH=7.0); reservoir solution: 50 mM sodium cacodylate trihydrate, 80 mM Mg(Ac)2 and 25% w/v PEG 8000 at pH=6.5; C): a-
chymotrypsinogen A(II) (Chy.A) solution: 20 mg/mL a-chymotrypsinogen A(II) in 0.1 M citric acid (pH=3.5) and 12.5% w/v PEG 3350; reservoir
solution: 25% w/v PEG 3350; D): concanavalin A (Con.A) solution: 20 mg/mL in 25 mM HEPES-Na (pH=7.0); reservoir solution: 0.1 M Tris-HCl and 8%
w/v PEG 8000 at pH=8.5.
doi:10.1371/journal.pone.0017950.g006
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chosen arbitrarily in most labs. When a crystallization screening
experiment yields no hits, it is hard to know if the cause was an
unsuitable temperature or unsuitable solution conditions. If the
chosen temperature is shown to be unsuitable after a couple of
trials, it must be changed to other temperatures using only trial
and error tests, which will waste time, money, and protein before a
suitable temperature is found. Therefore, determining a more
favorable temperature in advance will be very useful for carrying
out the crystallization screens more easily and efficiently. The
method proposed in this paper was proven effective, and we
recommend it as an alternative method to rationally find a suitable
temperature for protein crystallization screens.
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